BioSig Technologies, Inc.

WHO'M
ai
Digital Profiler. Einfach den AI-Button klicken
CUSIP
09073N300
SEDOL
N/A
CIK
0001530766
www.biosig.com
LEI:
©
New: Infographics X-Lab
FIGI: BBG006MM6RH9
BSGM
BioSig Technologies, Inc.
GICS: - · Sektor: Healthcare · Sub-Sektor: Medical Devices
AI
PROFILER
NAME
BioSig Technologies, Inc.
ISIN
US09073N3008
TICKER
BSGM
MIC
XNAS
REUTERS
BSGM.OQ
BLOOMBERG
BSGM US
F&G: 75
6.254,96 S&P · 17,28 Vola-Index · 118.562,61 BTC · 1,16904 EURUSD
BUILD THEMEFOLIO IDEEN TEILEN DISKUTIEREN
HEBEL INVESTIEREN
Financial Intelligence
360° iHub Crowd ATH Tracker Index Tracker ETF TF Spicy X-Billboard
FÜR INVESTOREN
FÜR TRADER
Börsenhandel
Der X-News Explorer ist die ultimative Informationsquelle für börsenaffine Anleger, die sich schnell und komfortabel einen Überblick über die aktuelle Nachrichtenlage eines börsennotierten Unternehmens verschaffen möchten. Ihnen stehen hier verschiedene Newswire-Services zur Verfügung. Wird ein News-Alert angezeigt, liegen Unternehmensnachrichten vor, die Sie möglicherweise interessieren könnten. Dieser Service wird Ihnen von BusinessWire bereitgestellt.
Fr., 11.07.2025       BioSig Technologies
US09073N3008

BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), is pleased to announce the appointment of Russell Starr as Strategic Advisor to Streamex. Mr. Starr brings decades of experience in capital markets, business development, and transformative deal-making across...
weiterlesen
BioSig Technologies
Research & Analysen Termsheet Terminal
Permalink
Di., 08.07.2025       BioSig Technologies
US09073N3008

BioSig Technologies, Inc. (“BioSig” or the “Company”), which recently merged with Streamex Exchange Corporation (“Streamex”) (Nasdaq: BSGM), announced today that the Company has entered into definitive agreements with a leading institutional investor for up to US$1.1 billion in growth financing, positioning the Company to become one of Nasdaq’s la...
weiterlesen
BioSig Technologies
Research & Analysen Termsheet Terminal
Permalink
Sa., 31.05.2025       BioSig Technologies
US09073N3008

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of BioSig Technologies, Inc. (NasdaqCM: BSGM) and Streamex Exchange Corporation. Upon closing of the proposed transaction, current BioSig shareholders and holders of common stock equivalents w...
weiterlesen
BioSig Technologies
Research & Analysen Termsheet Terminal
Permalink
Mo., 26.05.2025       BioSig Technologies
US09073N3008

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of BioSig Technologies, Inc. (NASDAQ: BSGM) and Streamex Exchange Corporation is fair to BioSig shareholders. Upon completion of the proposed transaction, current BioSig shareholders and holders of common stock equivalents will hold 25% of the fully diluted BioSig c...
weiterlesen
BioSig Technologies
Research & Analysen Termsheet Terminal
Permalink
We are different
OPEN FINANCIAL
DATA & KNOWLEDGE HUB
We make the difference
Informationen zu Product Placements

 

BARRISTA SMART * AD

P R O D U C T   S U G G E S T I O N S